Neurotransmitter receptor imbalances in motor cortex and basal ganglia in Hepatic Encephalopathy

Cellular Physiology and Biochemistry

Volumn 24, Issue 3-4, 2009, Pages 291-306

  Palomero Gallagher, Nicola ^a,b   Bidmon, Hans Jürgen ^c   Cremer, Markus ^a   Schleicher, Axel ^c   Kircheis, Gerald ^c   Reifenberger, Guido ^c   Kostopoulos, George ^d   Häussinger, Dieter ^c   Zilles, Karl ^a,b,c,e  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b JARA Translational Brain Medicine   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF PATRAS   (Greece)

^e Brain Imaging Center West   (Germany)

Author keywords

Acetylcholine; Adenosine; Human post mortem brain tissue; Neurotransmitter receptors; Putamen

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ACETYLCHOLINE; ADENOSINE; ADENOSINE RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMPA RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMIC ACID; KAINIC ACID RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING ASSAY; BINDING KINETICS; BINDING SITE; CADAVER; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOWN REGULATION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MOTOR CORTEX; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PUTAMEN; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALIA;

EID: 68349148262     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000233254     Document Type: Article

References (75)

1. Häussinger D, Schliess F: Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008;57:1156-1165.
2. Felipo V: Hyperammonemia; in Handbook of Neurochemistry and Molecular Neurobiology: Berlin, Heidelberg, Springer-Verlag, 2007.
3. Ahboucha S, Butterworth RF: Pathophysiology of hepatic encephalopathy: A new look at GABA from the molecular standpoint. Metab Brain Dis 2004;19:331-343.
4. Baraldi M, Zeneroli ML, Ventura E, Penne A, Pinelli G, Ricci P, Santi M: Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin Sci 1984;67:167-175.
5. Vogels BAP, Maas MAW, daalhuisen J, Quack G, Chamuleau RAFM: Memantine, a non-competitive NMDA-receptor antagonist improves hyperamonemiainduced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 1997;25:820-827.
6. Hadesman R, Wiesner RH, Go VLW, Tyce G-M: Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathy. J Neurochem 1995;65:1166-1175.
7. Hermenegildo C, Monfort P, Felipo V: Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis. Hepatology 2000;31:709-715.
8. 3 H]amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy. J Neurochem 1991;56:1881-1888.
9. A receptor: lack of effect of portacaval shunting. J Cereb Blood Flow Metab 1991;12:334-346.
10. McCandless DW, Looney GA, Modak AT, Stavinoha WB: Cerebral acetylcholine and energy metabolism changes in acute ammonia intoxication in the lower primate Tupaia glis. J Lab Clin Med 1985;106:183-186.
11. Michalak A, Chatauret N, Butterworth RF: Evidence for a serotonin transporter deficit in experimental acute liver failure. Neurochem Int 2001;38:163-168.
12. Michalak A, Rose C, Buu PNT, Butterworth RF: Evidence for altered central noradrenergic function in experimental acute liver failure in the rat. Hepatology 1998;27:362-368.
13. Oja SS, Borkowska HD, Albrecht J, Saransaari P: Kainate and AMPA receptors in the rat brain in thioacetamide-induced hepatic encephalopathy. Proc West Pharmacol Soc 1996;39:15-17.
14. 3 H]glutamate binding sites in rat brain following portacaval anastomosis. J Neurochem 1990;55:386-390.
15. Roy S, Pomier-Layrargues G, Butterworth RF, Huet PM: Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology 1988;8:845-849.
16. Schafer DF, Fowler JM, Munson PJ, Thakur AK, Waggoner JG, Jones EA: Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J Lab Clin Med 1983;102:870-880.
17. Schafer DF, Jones EA: Hepatic encephalopathy and the gammaaminobutyric- acid neurotransmitter system. Lancet 1982;1:18-20.
18. Schliess F, Görg B, Fischer R, Desjardins P, Bidmon H-J, Herrmann A, Butterworth RF, Zilles K, Häussinger D: Ammonia induces MK-801-sensitive nitration and phosphorilation of protein tyrosine residues in rat astrocytes. FASEB J 2002;16:739-741.
19. Song G, Dhodda VK, Blei AT, Dempsey RJ, Rao VL: GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res 2002;68:1072-1086.
20. Ha JH, Basile AS: Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res 1996;720:35-44.
21. B binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res 1993;629:355-357.
22. Rao VLR, Agrawal AK, Murthy CRK: Ammonia-induced alterations in glutamate and muscimol binding to cerebellar synaptic membranes. Neurosci Lett 1991;130:251-254.
23. García-Ayllón MS, Cauli O, Silveyra MX, Rodrigo R, Candela A, Compañ A, Jover R, Pérez-Mateo M, Martínez S, Felipo V, Sáez-Valero J: Brain cholinergic impairment in liver failure. Brain 2008;131:2946-2956.
24. Palomero-Gallagher N, Reifenberger G, Kostopoulos G, Kircheis G, Häussinger D, Zilles K: Neurotransmitter receptor alterations in hepatic encephalopathy; in Häussinger D, Kircheis G, Schliess F (eds): Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht, Springer, 2006, pp 255-272.
25. Ahboucha S, Desjardins P, Chatauret N, Pomier-Layrargues G, Butterworth RF: Normal coupling of brain benzodiazepine and neurosteroid modulatory sites of the GABA-A receptor complex in human hepatic encephalopathy. Neurochem Int 2003;43:551-556.
26. Lavoie J, Giguère J-F, Pomier-Layrargues G, Butterworth RF: Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 1987;49:692-697.
27. Ahboucha S, Araqi F, Pomier-Layrargues G, Butterworth RF: Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain. Neurochem Int 2005;47:58-63.
28. 3 H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology 1988;8:1084-1088.
29. Dodd PR, Thomas GJ, Harper CG, Kril JJ: Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J Neurochem 1992;59:1506-1515.
30. Lal S, Quirion R, Lafaille F, Nair NP, Loo P, Braunwalder A, Wood P, Williams M: Muscarinic, benzodiazepine, GABA, chloride channel and other binding sites in frontal cortex in hepatic coma in man. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:243-250.
31. Lavoie J, Layrargues GP, Butterworth RF: Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. Hepatology 1990;11:874-878.
32. Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K, Bauer A: Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging 2008;35:589-597.
33. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J: Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-1480.
34. Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P, Keiding S: Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. Eur J Nucl Med Mol Imaging 2006;33:810-816.
35. 3 H]5- fluoro-willardiine in the brains of rats with acute liver failure. Hepatology 1997;25:631-635.
36. Michalak A, Rose C, Butterworth J, Butterworth RF: Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 1996;24:908-913.
37. Görg B, Qvartskhava N, Keitel V, Bidmon H-J, Selbach O, Schliess F, Häussinger D: Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo. Hepatology 2008;48:567-579.
38. Cauli O, Mansouri MT, Agusti A, Felipo V: Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 2009;136:1359-2.
39. Bidmon H-J, Speckmann E-J, Zilles K: Seizure semiology, neurotransmitter receptors and cellular stress responses in pentylenetetrazole models of epilepsy. European Neurological Reviews 2009 in press.
40. Ferenci P, Pappas SC, Munson PJ, Henson K, Jones EA: Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy. Hepatology 1984;4:186-191.
41. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT: Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
42. Zilles K, Palomero-Gallagher N, Grefkes C, Scheperjans F, Boy C, Amunts K, Schleicher A: Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry. European Neuropsychopharmacology 2002;12:587-599.
43. Bauer A, Holschbach MH, Cremer M, Weber S, Boy C, Shah NJ, Olsson RA, Halling H, Coenen HH, Zilles K: Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET. J Nucl Med 2003;44:1682-1689.
44. Bethmann K, Fritschy JM, Brandt C, Loscher W: Antiepileptic drug resistant rats differ from drug responsive rats in GABA A receptor subunit expression in a model of temporal lobe epilepsy. Neurobiol Dis 2008;31:169-187.
45. Ribeiro JA, Sebastião AM, de Mendoça A: Participation of adenosine receptors in neuroprotection. Dru News Perspect 2003;16:80-86.
46. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-552.
47. Schmidt W, Wolf G, Grüngreiff K, Linke K: Adenosine influences the high-affinity uptake of transmitter glutamate and aspartate under conditions of hepatic encephalopathy. Metab Brain Dis 1993;8:73-80.
48. Ciruela F, Ferre S, Casado V, Cortes A, Cunha RA, Lluis C, Franco R: Heterodimeric adenosine receptors: a device to regulate neurotransmitter release. Cell Mol Life Sci 2006;63:2427-2431.
49. Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R: Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 2006;26:2080-2087.
50. Dunwiddie TV, Masino SA: The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001;24:31-55.
51. Brown SJ, James S, Reddington M, Richardson PJ: Both A1 and A2a purine receptors regulate striatal acetylcholine release. J Neurochem 1990;55:31-38.
52. 3 H]acetylcholine release. J Neurochem 1994;62:960-966.
53. Rebola N, Lujan R, Cunha RA, Mulle C: Adenosine A2A receptors are essential for long-term potentiation of NMDAEPSCs at hippocampal mossy fiber synapses. Neuron 2008;57:121-134.
54. 3 H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 2000;39:1156-1167.
55. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K: Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997;20:482-487.
56. Cunha RA, Ferre S, Vaugeois JM, Chen JF: Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 2008;14:1512-1524.
57. Cunha RA: Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade. Purinergic Signal 2005;1:111-134.
58. Arnaiz-Cot JJ, Gonzalez JC, Sobrado M, Baldelli P, Carbone E, Gandia L, Garcia AG, Hernandez-Guijo JM: Allosteric modulation of alpha7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission. Eur J Neurosci 2008;27:1097-1110.
59. Li F, Endo T, Isa T: Presynaptic muscarinic acetylcholine receptors suppress GABAergic synaptic transmission in the intermediate grey layer of mouse superior colliculus. Eur J Neurosci 2004;20:2079-2088.
60. Murthy CRK, Norenberg MD: Suppression of ammonia-induced swelling by aspartate but not by ornithine in primary cultures of rat astrocytes. Neurochem Int 2002;41:171-176.
61. Sas K, Robotka H, Toldi J, Vecsei L: Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007;257:221-239.
62. Erhardt S, Olsson SK, Engberg G: Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs 2009;23:91-101.
63. Saran T, Hilgier W, Urbanska EM, Turski WA, Albrecht J: Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamideinduced hepatic encephalopathy. J Neurosci Res 2004;75:436-440.
64. Saran T, Hilgier W, Kocki T, Urbanska EM, Turski WA, Albrecht J: Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices. Brain Res 1998;787:348-350.
65. Moroni F, Lombardi G, Carla V, Pellegrini D, Carassale GL, Cortesini C: Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. J Neurochem 1986;46:869-874.
66. Cauli O, Lopez-Larrubia P, Rodrigues TB, Cerdan S, Felipo V: Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors. J Neurochem 2007;103:1334-1343.
67. Ferenci P, Jacobs R, Pappas SC, Schafer DF, Jones EA: Enzymes of cerebral GABA metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: evidence for decreased cerebral GABA-transaminase activity. J Neurochem 1984;42:1487-1490.
68. Li XQ, Dong L, Liu ZH, Luo JY: Expression of gamma-aminobutyric acid A receptor subunits a1, b1, g2 mRNA in rats with hepatic encephalopathy. World J Gastroenterol 2005;11:3319-3322.
69. Jalan R, Turjanski N, Taylor-Robinson-S.D., Koepp MJ, Richardson MP, Wilson JA, Bell JD, Brooks DJ: Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut 2000;46:546-552.
70. Swapna I, SathyaSaikumar KV, Murthy C, Gupta AD, Senthilkumaran B: Alterations in kinetic and thermotropic properties of cerebral membrane-bound acetylcholineesterase during thioacetamide-induced hepatic encephalopathy: correlation with membrane lipid changes. Brain Res 2007;1153:188-195.
71. Bergqvist PBH, Hjorth S, Audet R, Apelquist G, Bengtsson F, Butterworth RF: Ammonium acetate challenge in experimental hepatic encephalopathy induces a transient increase of brain HT release in vivo. Eur Psychopharmacol 1996;6:317-322.
72. Rao VL, Butterworth RF: Alterations of [3H]8-OH-DPAT and [3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci Lett 1994;182:69-72.
73. Kaneko K, Kurumaji A, Watanabe A, Yamada S, Toru M: Changes in high K+-evoked serotonin release and serotonin2A/2C receptor binding in the frontal cortex of rats with thioacetamideinduced hepatic encephalopathy. J Neural Transm 1998;105:13-20.
74. Mousseau DD, Perney P, Layrargues GP, Butterworth RF: Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 1993;162:192-196.
75. Waskiewicz J, Fresko I, Lenkiewicz A, Albrecht J: Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure. Brain Res 2001;900:143-145.